Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cowan M, Swetzig WM, Adorno-Cruz V, Pineda MJ, et al. Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial. Gynecol Oncol 2021 Aug 18. pii: S0090-8258(21)00650.
PMID: 34419285


Privacy Policy